[PharmaEssentia] Announcement of the Board of Directors' Approval of the Q1 2026 Consolidated Financial Report
PharmaEssentia's Board of Directors approved its Q1 2026 consolidated financial report (January 1 to March 31, 2026). The company reported strong financial results with cumulative operating revenue of NTD 5,121,378 thousand, net profit of NTD 2,149,627 thousand, and basic earnings per share of NTD 5.79.
📋 Article Processing Timeline
- 📰 Published: May 13, 2026 at 09:00
- 🔍 Collected: May 14, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 14, 2026 at 09:02 (1h 2m after Collected)
1. Date of report to the Board of Directors or resolution by the Board of Directors: 2026/05/13
2. Date of approval by the Audit Committee: 2026/05/13
3. Reporting period of financial report or annual self-reported financial information: 2026/01/01~2026/03/31
4. Cumulative operating revenue from January 1 to the current period (in thousands of NTD): 5,121,378
5. Cumulative operating gross profit (gross loss) from January 1 to the current period (in thousands of NTD): 4,500,097
6. Cumulative operating income (loss) from January 1 to the current period (in thousands of NTD): 2,087,077
7. Cumulative pre-tax net profit (net loss) from January 1 to the current period (in thousands of NTD): 2,335,581
8. Cumulative net profit (net loss) for the current period from January 1 to the current period (in thousands of NTD): 2,149,627
9. Cumulative net profit (net loss) attributable to owners of the parent from January 1 to the current period (in thousands of NTD): 2,149,627
10. Cumulative basic earnings per share (loss) from January 1 to the current period (in NTD): 5.79
11. Total assets at period-end (in thousands of NTD): 40,089,669
12. Total liabilities at period-end (in thousands of NTD): 5,635,458
13. Equity attributable to owners of the parent at period-end (in thousands of NTD): 34,454,211
14. Other matters that should be specified: None.
2. Date of approval by the Audit Committee: 2026/05/13
3. Reporting period of financial report or annual self-reported financial information: 2026/01/01~2026/03/31
4. Cumulative operating revenue from January 1 to the current period (in thousands of NTD): 5,121,378
5. Cumulative operating gross profit (gross loss) from January 1 to the current period (in thousands of NTD): 4,500,097
6. Cumulative operating income (loss) from January 1 to the current period (in thousands of NTD): 2,087,077
7. Cumulative pre-tax net profit (net loss) from January 1 to the current period (in thousands of NTD): 2,335,581
8. Cumulative net profit (net loss) for the current period from January 1 to the current period (in thousands of NTD): 2,149,627
9. Cumulative net profit (net loss) attributable to owners of the parent from January 1 to the current period (in thousands of NTD): 2,149,627
10. Cumulative basic earnings per share (loss) from January 1 to the current period (in NTD): 5.79
11. Total assets at period-end (in thousands of NTD): 40,089,669
12. Total liabilities at period-end (in thousands of NTD): 5,635,458
13. Equity attributable to owners of the parent at period-end (in thousands of NTD): 34,454,211
14. Other matters that should be specified: None.